Luana S Lenz

15PUBLICATIONS
44CO-AUTHORS
Haematological tumoursEpigenetics (incl. genome methylation and epigenomics)Cancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jan 29, 2026
Temozolomide increases the generation of cell heterogeneity in ERK activity in glioma cells.

Karine Rech Begnini, Julia Caroline Marcolin, Luiza Cherobini Pereira

|May 14, 2025
Assessing Ecto-5'-Nucleotidase/CD73 Expression and Malignancy Parameters in Early- and Late- Passage C6 Glioma Cells.

Fabiana M Manica, Luis Felipe I Campesato, Juliete Nathali Scholl

|Jun 06, 2024
Population dynamics is a cancer driver.

Mariana Dos Santos Oliveira, Marcelo de C Griebeler, Bernardo Henz

|Feb 09, 2024
The contribution of asymmetric cell division to phenotypic heterogeneity in cancer.

Julieti Huch Buss, Karine Rech Begnini, Guido Lenz

|Feb 24, 2022
A DNA repair-independent role for alkyladenine DNA glycosylase in alkylation-induced unfolded protein response.

Larissa Milano, Clara F Charlier, Rafaela Andreguetti

|Feb 15, 2022
Bioimaging approaches for quantification of individual cell behavior during cell fate decisions.

Karine R Begnini, Luiza C Pereira, Juliano L Faccioni

Pageof 3